Peers & Perspectives in Oncology
August II, 2024
Volume: 2
Issue: 12
July 2024
June II, 2024
June I 2024
May 2024
Volume: 2
Issue: 7
April II, 2024
April I, 2024
March 2024
February II, 2024
Volume: 2
Issue: 3
February I, 2024
Volume: 2
Issue: 2
January 2024
Volume: 2
Issue: 1
December II, 2023
Volume: 1
Issue: 11
December I, 2023
Volume: 1
Issue: 10
November II, 2023
Volume: 1
Issue: 9
November I, 2023
Volume: 1
Issue: 8
October II 2023
Volume: 1
Issue: 7
October I 2023
Volume: 1
Issue: 6
September 2023
Volume: 1
Issue: 5
August 2023
Volume: 1
Issue: 4
July II 2023
Volume: 1
Issue: 3
July I 2023
Volume: 1
Issue: 2
June 2023
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Behind the FDA Approval: Daraxonrasib Delivers in Pancreatic Cancer
2
FDA Grants Fast Track Designation to ADC Varseta-M for mCRC
3
White Blood Cell Count May Help Refine Risk Assessment in Polycythemia Vera
4
Strategies Shift Beyond Traditional Management of Immune Thrombocytopenia
5